Published in J Am Chem Soc on April 30, 2008
Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide. J Mol Biol (2009) 1.53
Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome. Proc Natl Acad Sci U S A (2010) 1.48
Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Biochemistry (2008) 1.47
Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc Chem Res (2011) 1.46
Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity. Proc Natl Acad Sci U S A (2011) 1.37
Beyond NMR spectra of antimicrobial peptides: dynamical images at atomic resolution and functional insights. Solid State Nucl Magn Reson (2009) 1.33
A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. Biochemistry (2008) 1.27
Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J Am Chem Soc (2009) 1.26
Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide. J Am Chem Soc (2009) 1.25
2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure. J Am Chem Soc (2011) 1.20
Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim Biophys Acta (2011) 1.20
Chemical shift tensor - the heart of NMR: Insights into biological aspects of proteins. Prog Nucl Magn Reson Spectrosc (2010) 1.18
A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes. Chem Biol (2009) 1.18
Development and validation of transferable amide I vibrational frequency maps for peptides. J Phys Chem B (2011) 1.18
Role of zinc in human islet amyloid polypeptide aggregation. J Am Chem Soc (2010) 1.11
Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity. FEBS Lett (2013) 1.08
Islet amyloid polypeptide toxicity and membrane interactions. Proc Natl Acad Sci U S A (2013) 1.06
NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286). J Am Chem Soc (2009) 1.06
Solution state structures of human pancreatic amylin and pramlintide. Protein Eng Des Sel (2009) 1.00
Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion. Biophys J (2009) 1.00
Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Sci Rep (2014) 0.98
Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. Biophys J (2011) 0.97
K3 fragment of amyloidogenic beta(2)-microglobulin forms ion channels: implication for dialysis related amyloidosis. J Am Chem Soc (2009) 0.97
A membrane-bound antiparallel dimer of rat islet amyloid polypeptide. Angew Chem Int Ed Engl (2011) 0.95
Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. Biochemistry (2012) 0.95
A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc. J Mol Biol (2011) 0.91
Amyloidogenesis abolished by proline substitutions but enhanced by lipid binding. PLoS Comput Biol (2009) 0.91
α-helical structures drive early stages of self-assembly of amyloidogenic amyloid polypeptide aggregate formation in membranes. Sci Rep (2013) 0.90
Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation. PLoS Pathog (2012) 0.90
Simultaneous capillary electrophoresis competitive immunoassay for insulin, glucagon, and islet amyloid polypeptide secretion from mouse islets of Langerhans. J Chromatogr A (2011) 0.89
N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly. J Biol Chem (2010) 0.88
Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes. PLoS One (2013) 0.88
Probing ion channel activity of human islet amyloid polypeptide (amylin). Biochim Biophys Acta (2012) 0.86
Bayesian total internal reflection fluorescence correlation spectroscopy reveals hIAPP-induced plasma membrane domain organization in live cells. Biophys J (2014) 0.86
Lipid interaction and membrane perturbation of human islet amyloid polypeptide monomer and dimer by molecular dynamics simulations. PLoS One (2012) 0.85
Retinal dynamics during light activation of rhodopsin revealed by solid-state NMR spectroscopy. Biochim Biophys Acta (2009) 0.85
Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology. J Diabetes Res (2015) 0.83
Inhibition of Toxic IAPP Amyloid by Extracts of Common Fruits. J Funct Foods (2015) 0.82
The role of aromatic side-chains in amyloid growth and membrane interaction of the islet amyloid polypeptide fragment LANFLVH. Eur Biophys J (2010) 0.81
The role of the disulfide bond in the interaction of islet amyloid polypeptide with membranes. Eur Biophys J (2010) 0.80
Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20-29) fragments. Phys Chem Chem Phys (2013) 0.80
Adsorption and Orientation of Human Islet Amyloid Polypeptide (hIAPP) Monomer at Anionic Lipid Bilayers: Implications for Membrane-Mediated Aggregation. Int J Mol Sci (2013) 0.79
Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions. J Mol Biol (2012) 0.77
Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption. J Biol Chem (2015) 0.77
Misfolding of amyloidogenic proteins and their interactions with membranes. Biomolecules (2013) 0.77
Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives. Int J Mol Sci (2015) 0.77
IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-β-D-glucose. Amyloid (2013) 0.77
Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis. Adv Exp Med Biol (2015) 0.77
Amylin analogues in the treatment of diabetes mellitus: medicinal chemistry and structural basis of its function. Open Med Chem J (2011) 0.76
Mechanism of Inhibition of Human Islet Amyloid Polypeptide-Induced Membrane Damage by a Small Organic Fluorogen. Sci Rep (2016) 0.76
Interaction of IAPP and insulin with model interfaces studied using neutron reflectometry. Biophys J (2009) 0.76
The Effects of Lipid Membranes, Crowding and Osmolytes on the Aggregation, and Fibrillation Propensity of Human IAPP. J Diabetes Res (2015) 0.75
On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides. J Diabetes Res (2015) 0.75
Direct observation of defects and increased ion permeability of a membrane induced by structurally disordered Cu/Zn-superoxide dismutase aggregates. PLoS One (2011) 0.75
Binding Orientations and Lipid Interactions of Human Amylin at Zwitterionic and Anionic Lipid Bilayers. J Diabetes Res (2015) 0.75
Facet-Dependent Interactions of Islet Amyloid Polypeptide with Gold Nanoparticles: Implications for Fibril Formation and Peptide-Induced Lipid Membrane Disruption. Chem Mater (2017) 0.75
Influence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid Polypeptide. J Diabetes Res (2016) 0.75
Probing amylin fibrillation at an early stage via a tetracysteine-recognising fluorophore. Talanta (2017) 0.75
Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A (1998) 4.72
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem (2005) 4.23
Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry (2007) 3.57
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem (2007) 3.42
The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes (1999) 3.30
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A (1990) 3.29
Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol (2004) 2.46
Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol (2000) 2.34
Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. Biochemistry (2006) 2.25
Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem (1996) 2.01
Lipid membranes modulate the structure of islet amyloid polypeptide. Biochemistry (2005) 1.99
Structures for amyloid fibrils. FEBS J (2005) 1.98
Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol (2000) 1.95
Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry (2002) 1.95
Folding of beta-sheet membrane proteins: a hydrophobic hexapeptide model. J Mol Biol (1998) 1.82
Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life (2007) 1.81
Fiber-dependent amyloid formation as catalysis of an existing reaction pathway. Proc Natl Acad Sci U S A (2007) 1.75
The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J (2006) 1.68
Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett (2004) 1.59
Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol (2001) 1.57
The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. J Mol Biol (2005) 1.56
Membrane interaction of islet amyloid polypeptide. Biochim Biophys Acta (2007) 1.54
On the analysis of membrane protein circular dichroism spectra. Protein Sci (2004) 1.52
Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am J Physiol Endocrinol Metab (2006) 1.47
Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry (2007) 1.44
Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. J Mol Biol (2005) 1.35
Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. Biochim Biophys Acta (2007) 1.34
Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys J (2007) 1.27
Conformational preferences of the amylin nucleation site in SDS micelles: an NMR study. Biopolymers (2003) 1.17
Pore-forming proteins share structural and functional homology with amyloid oligomers. Neuromolecular Med (2007) 1.12
Solid-state NMR as a probe of amyloid fibril structure. Curr Opin Chem Biol (2000) 1.12
Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. Biopolymers (2001) 1.10
Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid. Protein Sci (2004) 1.09
Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside. Peptides (2004) 0.97
Ultrastrong and stiff layered polymer nanocomposites. Science (2007) 3.40
Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta (2007) 3.24
LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta (2006) 3.05
Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. Biophys J (2005) 1.81
NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry (2008) 1.65
The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta (2006) 1.62
Solid-state NMR reveals structural and dynamical properties of a membrane-anchored electron-carrier protein, cytochrome b5. J Am Chem Soc (2007) 1.53
A partially folded structure of amyloid-beta(1-40) in an aqueous environment. Biochem Biophys Res Commun (2011) 1.51
An innovative procedure using a sublimable solid to align lipid bilayers for solid-state NMR studies. Biophys J (2002) 1.50
Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Biochemistry (2008) 1.47
The cytochromes P450 and b5 and their reductases--promising targets for structural studies by advanced solid-state NMR spectroscopy. Biochim Biophys Acta (2007) 1.47
Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc Chem Res (2011) 1.46
Structural plasticity of an acid-activated chaperone allows promiscuous substrate binding. Proc Natl Acad Sci U S A (2009) 1.46
Optically controlled locking of the nuclear field via coherent dark-state spectroscopy. Nature (2009) 1.46
Misfolded proteins in Alzheimer's disease and type II diabetes. Chem Soc Rev (2011) 1.45
Structure and orientation of pardaxin determined by NMR experiments in model membranes. J Biol Chem (2004) 1.38
Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity. Proc Natl Acad Sci U S A (2010) 1.37
Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. Biochim Biophys Acta (2007) 1.34
The magic of bicelles lights up membrane protein structure. Chem Rev (2012) 1.33
Coherent optical spectroscopy of a strongly driven quantum dot. Science (2007) 1.32
Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin. Biochim Biophys Acta (2008) 1.31
Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. Biophys J (2012) 1.31
Small molecule modulators of copper-induced Abeta aggregation. J Am Chem Soc (2009) 1.30
Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. J Am Chem Soc (2009) 1.29
Heteronuclear isotropic mixing separated local field NMR spectroscopy. J Chem Phys (2006) 1.27
A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. Biochemistry (2008) 1.27
Time-resolved dehydration-induced structural changes in an intact bovine cortical bone revealed by solid-state NMR spectroscopy. J Am Chem Soc (2009) 1.26
Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J Am Chem Soc (2009) 1.26
Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide. J Am Chem Soc (2009) 1.25
Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. Biochemistry (2006) 1.24
Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides. Biochemistry (2010) 1.24
Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc (2009) 1.24
Determination of the oligomer size of amyloidogenic protein beta-amyloid(1-40) by single-molecule spectroscopy. Biophys J (2009) 1.24
Amyloid-beta membrane binding and permeabilization are distinct processes influenced separately by membrane charge and fluidity. J Mol Biol (2008) 1.22
Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim Biophys Acta (2011) 1.20
Chemical shift tensor - the heart of NMR: Insights into biological aspects of proteins. Prog Nucl Magn Reson Spectrosc (2010) 1.18
Conformational preferences of the amylin nucleation site in SDS micelles: an NMR study. Biopolymers (2003) 1.17
The spectrum of antimicrobial activity of the bacteriocin subtilosin A. J Antimicrob Chemother (2007) 1.17
Bicelle-enabled structural studies on a membrane-associated cytochrome B5 by solid-state MAS NMR spectroscopy. Angew Chem Int Ed Engl (2008) 1.17
Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286). J Phys Chem B (2012) 1.14
Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers. Langmuir (2005) 1.13
Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers. Biochemistry (2010) 1.13
A model of the membrane-bound cytochrome b5-cytochrome P450 complex from NMR and mutagenesis data. J Biol Chem (2013) 1.12
Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β species. Proc Natl Acad Sci U S A (2013) 1.12
Role of zinc in human islet amyloid polypeptide aggregation. J Am Chem Soc (2010) 1.11
A high-resolution solid-state NMR approach for the structural studies of bicelles. J Am Chem Soc (2006) 1.11
Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry (2012) 1.11
Two-dimensional homonuclear chemical shift correlation established by the cross-relaxation driven spin diffusion in solids. J Chem Phys (2008) 1.10
Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease. J Am Chem Soc (2013) 1.07
Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target. Int J Biochem Cell Biol (2012) 1.07
Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim Biophys Acta (2005) 1.07
High-resolution 2D NMR spectroscopy of bicelles to measure the membrane interaction of ligands. J Am Chem Soc (2007) 1.07
NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286). J Am Chem Soc (2009) 1.06
Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins. Angew Chem Int Ed Engl (2011) 1.06
Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. Biophys J (2010) 1.06
NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization. J Biol Chem (2009) 1.05
Helical hairpin structure of a potent antimicrobial peptide MSI-594 in lipopolysaccharide micelles by NMR spectroscopy. Chemistry (2009) 1.04
Proton-evolved local-field solid-state NMR studies of cytochrome b5 embedded in bicelles, revealing both structural and dynamical information. J Am Chem Soc (2010) 1.03
Probing the spontaneous membrane insertion of a tail-anchored membrane protein by sum frequency generation spectroscopy. J Am Chem Soc (2010) 1.03
Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. Chem Phys Lipids (2005) 1.03
Solid-state NMR and molecular dynamics simulations reveal the oligomeric ion-channels of TM2-GABA(A) stabilized by intermolecular hydrogen bonding. Biochim Biophys Acta (2008) 1.02
Natural-abundance 43Ca solid-state NMR spectroscopy of bone. J Am Chem Soc (2010) 1.02
Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J Proteome Res (2011) 1.02
Sensitivity and resolution enhancement in solid-state NMR spectroscopy of bicelles. J Magn Reson (2006) 1.02
Use of a copper-chelated lipid speeds up NMR measurements from membrane proteins. J Am Chem Soc (2010) 1.01
Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1. Biochemistry (2008) 1.01
Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion. Biophys J (2009) 1.00
Resolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR. Biochemistry (2013) 0.99
Multifunctional host defense peptides: functional and mechanistic insights from NMR structures of potent antimicrobial peptides. FEBS J (2009) 0.99
Comprehensive analysis of lipid dynamics variation with lipid composition and hydration of bicelles using nuclear magnetic resonance (NMR) spectroscopy. Langmuir (2009) 0.98
Using fluorous amino acids to modulate the biological activity of an antimicrobial peptide. Chembiochem (2008) 0.98
Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. Chem Soc Rev (2014) 0.98
Direct observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrations. PLoS One (2011) 0.98
Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization. J Am Chem Soc (2010) 0.98
Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. Biophys J (2011) 0.97
Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline states in the presence of phosphatidylglycerol: lipid clustering in anionic membranes. Biophys J (2010) 0.96
Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species. Inorg Chem (2011) 0.95
NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. J Mol Biol (2011) 0.95
INEPT-based separated-local-field NMR spectroscopy: a unique approach to elucidate side-chain dynamics of membrane-associated proteins. J Am Chem Soc (2010) 0.95
Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochemistry (2005) 0.95
The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency. Biochim Biophys Acta (2011) 0.95
Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. Biochemistry (2012) 0.95
Effects of antidepressants on the conformation of phospholipid headgroups studied by solid-state NMR. Magn Reson Chem (2004) 0.94
Micelle formation by a fragment of human islet amyloid polypeptide. Biophys J (2003) 0.94
Membrane orientation of MSI-78 measured by sum frequency generation vibrational spectroscopy. Langmuir (2011) 0.94
Probing the transmembrane structure and topology of microsomal cytochrome-p450 by solid-state NMR on temperature-resistant bicelles. Sci Rep (2013) 0.93
Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequences. PeerJ (2013) 0.93
Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP. Biophys J (2013) 0.93
Single-molecule kinetics reveals signatures of half-sites reactivity in dihydroorotate dehydrogenase A catalysis. Proc Natl Acad Sci U S A (2006) 0.92
β-Amyloid (1-40) peptide interactions with supported phospholipid membranes: a single-molecule study. Biophys J (2012) 0.92